Career Enhancement Program

职业提升计划

• 批准号: 10480867
• 负责人: Jessie Villanueva
• 金额: $ 8.84万
• 依托单位: WISTAR INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-03 至 2026-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10480867
• 关键词: Acral Lentiginous Malignant Melanoma; Address; Awareness; Basal Cell Cancer; Cancer Center; Cancer Research Project; Career Mobility; Clinical; Cutaneous Melanoma; Department chair; Development; Ensure; Faculty; Financial Support; Fostering; Foundations; Funding; Funding Agency; Future; Goals; Grant; Institutes; Laboratories; Leadership; Measures; Melanoma Cell; Mentors; Mentorship; Minority; Monitor; Oral; Outcome; Paper; Peer Review; Pennsylvania; Policies; Positioning Attribute; Procedures; Progress Reports; Publications; Publishing; Research; Research Personnel; Research Project Grants; Resources; Skin Cancer; Solid; Squamous Cell; Talents; The Wistar Institute; Training; Training Support; Translational Research; Underrepresented Minority; Universities; Woman; Work; anticancer research; cancer subtypes; career; career development; diversity and inclusion; expectation; health disparity; high standard; innovation; interest; investigator training; meetings; melanoma; member; next generation; programs; recruit; research and development; success; translational cancer research; translational research program; translational scientist

Project Summary – Career Enhancement Program The goal of the Career Enhancement Program (CEP) is to recruit, train and retain a diverse pool of outstanding early-career investigators who are committed to pursuing translational skin cancer research. The CEP will be led by two established investigators with complementary expertise in basic (Dr. Villanueva) and clinical (Dr. Schuchter) melanoma research. Both co-Directors are committed to training and mentoring of translational investigators and have an established record of recruiting and supporting women and minorities. The CEP will primarily assist junior faculty in their career development, but more established investigators interested in refocusing their research efforts on melanoma/skin cancer could also be considered. Women and underrepresented minorities will be strongly encouraged to participate. Likewise, projects aimed at addressing health disparities and/or skin cancer subtypes more common in underrepresented minorities will be encouraged and given special consideration. A team of clinicians, educators and researchers with broad expertise in translational research will ensure implementation of the specific aims of this program. With the support of the University of Pennsylvania, the Abramson Cancer Center and The Wistar Institute, the CEP will provide junior faculty the resources and guidance needed to establish innovative and fully funded independent skin cancer research programs and become future academic leaders. The CEP will provide awardees with two years of financial support for translational research projects in skin cancer with potential promotion to full SPORE projects or independent grant support. Awardees are required to actively participate in SPORE functions, use the SPORE Core resources, and provide both formal written progress reports and oral presentations. We have established high standards and expectations for the research mentors and a formalized program of long-term awardee mentorship. The program measures success by resulting publications, funding, and ultimately career advancement and national recognition. We have an outstanding talent pool of candidates and an effective training and mentorship program that will result in an exceptional group of skin cancer researchers. Our SPORE CEP has had an outstanding record recruiting and training investigators for careers in translational skin cancer research. Our past CEP awardees have published 74 papers during the past cycle and have been highly successful in obtaining peer reviewed funding from NCI and/or other funding agencies. In addition, all past awardees have transitioned from young investigators into leading academic positions and remain in the skin cancer field.

计划摘要-职业提升计划 职业提升计划（CEP）的目标是招募，培训和留住一个优秀的多元化人才库。 致力于从事转化性皮肤癌研究的早期职业研究人员。CEP将由 由两名在基础（Villanueva博士）和临床（Dr. Schuchter）黑素瘤研究。两位联合主任都致力于培训和指导翻译 调查员，并有招募和支持妇女和少数民族的既定记录。卓越医療中心将 主要是帮助初级教师在他们的职业发展，但更多的建立调查感兴趣的是， 还可以考虑将研究工作的重点重新放在黑色素瘤/皮肤癌上。妇女和 将大力鼓励代表性不足的少数群体参加。同样，旨在解决 健康差异和/或皮肤癌亚型在代表性不足的少数群体中更为常见， 并给予特殊考虑。一个由临床医生、教育工作者和研究人员组成的团队，在以下方面具有广泛的专业知识： 转化研究将确保实现该方案的具体目标。的支持下 宾夕法尼亚大学，Abramson癌症中心和Wistar研究所，CEP将提供初级 教师提供建立创新且资金充足的独立皮肤癌所需的资源和指导 研究项目，成为未来的学术领袖。CEP将为获奖者提供两年的 为皮肤癌转化研究项目提供财政支持，并有可能推广到完整的SPORE项目 或独立资助。获奖者必须积极参与SPORE功能，使用SPORE 核心资源，并提供正式的书面进度报告和口头报告。我们建立 对研究导师的高标准和期望以及长期获奖者的正式计划 导师制该计划衡量成功的结果出版物，资金，并最终职业生涯 进步和国家认可。我们拥有优秀的人才库， 培训和指导计划，将导致一个特殊的皮肤癌研究人员组。我们的孢子 CEP在招募和培训研究人员从事转化性皮肤癌研究方面有着出色的记录。 我们过去的CEP获奖者在过去的周期中发表了74篇论文，并非常成功地获得了 来自NCI和/或其他资助机构的同行评审资助。此外，所有过去的获奖者都从 年轻的研究人员进入领先的学术职位，并留在皮肤癌领域。